Recombinant C3adesArg/acylation stimulating protein (ASP) is highly bioactive: A critical evaluation of C5L2 binding and 3T3-L1 adipocyte activation

Molecular Immunology

Volumn 46, Issue 16, 2009, Pages 3207-3217

  Cui, Wei ^a,b   Lapointe, Marc ^a   Gauvreau, Danny ^a   Kalant, David ^b   Cianflone, Katherine ^a,b  

^a LAVAL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Adipocytes; C3adesArg; C5L2; G protein coupled receptor; gpr77; Triglyceride synthesis

Indexed keywords

ACYLATION STIMULATING PROTEIN; PROTEIN C5L2; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING KINETICS; CELL ACTIVATION; CELL STRAIN 3T3; CELL STRAIN HEK293; CHO CELL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CHO CELLS; COMPLEMENT C3A; CRICETINAE; CRICETULUS; FATTY ACIDS; HUMANS; MICE; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, CHEMOKINE; RECOMBINANT PROTEINS; VIPERIDAE;

ESCHERICHIA COLI; MUS;

EID: 70349443379     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2009.08.013     Document Type: Article

References (46)

1. Baldo A., Sniderman A.D., St Luce S., et al. Signal transduction pathway of acylation stimulating protein: involvement of protein kinase C. J. Lipid Res. 36 7 (1995) 1415-1426
2. Baldo A., Sniderman A.D., St-Luce S., et al. The adipsin-acylation stimulating protein system and regulation of intracellular triglyceride synthesis. J. Clin. Invest. 92 (1993) 1543-1547
3. Cain S.A., and Monk P.N. The orphan receptor C5L2 has high affinity binding sites for complement fragments C5a and C5a des-Arg(74). J. Biol. Chem. 277 9 (2002) 7165-7169
4. Camus G., Duchateau J., Deby-Dupont G., et al. Anaphylatoxin C5a production during short-term submaximal dynamic exercise in man. Int. J. Sports Med. 15 1 (1994) 32-35
5. Camus G., Poortmans J., Nys M., et al. Mild endotoxaemia and the inflammatory response induced by a marathon race. Clin. Sci. (Lond.) 92 4 (1997) 415-422
6. Chen N.J., Mirtsos C., Suh D., et al. C5L2 is critical for the biological activities of the anaphylatoxins C5a and C3a. Nature 446 7132 (2007) 203-207
7. Cianflone K., Kwiterovich P.O., Walsh M., et al. Stimulation of fatty acid uptake and triglyceride synthesis in human cultured skin fibroblasts and adipocytes by a serum protein. Biochem. Biophys. Res. Commun. 144 (1987) 94-100
8. Cianflone K., Xia Z., and Chen L.Y. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochim. Biophys. Acta 1609 2 (2003) 127-143
9. Cianflone K.M., Maslowska M.H., and Sniderman A.D. Impaired response of fibroblasts from patients with hyperapobetalipoproteinemia to acylation-stimulating protein. J. Clin. Invest. 85 3 (1990) 722-730
10. Cianflone K.M., Sniderman A.D., Walsh M.J., et al. Purification and characterization of acylation stimulating protein. J. Biol. Chem. 264 (1989) 426-430
11. Cui W., Paglialunga S., Kalant D., et al. Acylation-stimulating protein/C5L2-neutralizing antibodies alter triglyceride metabolism in vitro and in vivo. Am. J. Physiol. Endocrinol. Metab. 293 6 (2007) E1482-E1491
12. Cui W., Simaan M., Laporte S., Lodge R., and Cianflone K. C5a- and ASP-mediated C5L2 activation, endocytosis and recycling are lost in S323I-C5L2 mutation. Mol. Immunol. 46 15 (2009) 3086-3098
13. Dutta S., Ware L.A., Barbosa A., et al. Purification, characterization, and immunogenicity of a disulfide cross-linked plasmodium vivax vaccine candidate antigen, merozoite surface protein 1, expressed in Escherichia coli. Infect. Immun. 69 9 (2001) 5464-5470
14. Faraj M., Sniderman A.D., and Cianflone K. ASP enhances in situ lipoprotein lipase activity by increasing fatty acid trapping in adipocytes. J. Lipid Res. 45 4 (2004) 657-666
15. Flanagan C.A. A GPCR that is not "DRY". Mol. Pharmacol. 68 1 (2005) 1-3
16. Gao H., Neff T.A., Guo R.F., et al. Evidence for a functional role of the second C5a receptor C5L2. FASEB J. 19 8 (2005) 1003-1005
17. Gerard N.P., Lu B., Liu P., et al. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J. Biol. Chem. 280 48 (2005) 39677-39680
18. Gerard N.P., Lu B., Liu P., et al. An anti-inflammatory function for the complement anaphylatoxin C5a-binding protein, C5L2. J. Biol. Chem. 280 December (48) (2005) 39677-39680
19. Ho M., Foxall S., Higginbottom M., et al. Leptin-mediated inhibition of the insulin-stimulated increase in fatty acid uptake in differentiated 3T3-L1 adipocytes. Metabolism 55 1 (2006) 8-12
20. Huber-Lang M., Sarma J.V., Rittirsch D., et al. Changes in the novel orphan, C5a receptor (C5L2), during experimental sepsis and sepsis in humans. J. Immunol. 174 2 (2005) 1104-1110
21. Johswich K., Martin M., Thalmann J., et al. Ligand specificity of the anaphylatoxin C5L2 receptor and its regulation on myeloid and epithelial cell lines. J. Biol. Chem. 281 51 (2006) 39088-39095
22. Kalant D., Cain S.A., Maslowska M., et al. The chemoattractant receptor-like protein C5L2 binds the C3a des-Arg77/acylation-stimulating protein. J. Biol. Chem. 278 13 (2003) 11123-11129
23. Kalant D., MacLaren R., Cui W., et al. C5L2 is a functional receptor for acylation-stimulating protein. J. Biol. Chem. 280 25 (2005) 23936-23944
24. Lago F., Dieguez C., Gómez-Reino J., et al. The emerging role of adipokines as mediators of inflammation and immune responses. Cytokine Growth Factor Rev. 18 3/4 (2007) 313-325
25. Liao J., Sportsman R., Harris J., et al. Real-time quantification of fatty acid uptake using a novel fluorescence assay. J. Lipid Res. 46 3 (2005) 597-602
26. MacLaren R., Cui W., and Cianflone K. Adipokines and the immune system: an adipocentric view. Adv. Exp. Med. Biol. 632 (2008) 1-21
27. MacLaren R., Kalant D., and Cianflone K. The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochem. Cell. Biol. 85 1 (2007) 11-21
28. Marcil M., Vu H., Cui W., et al. Identification of a novel C5L2 variant (S323I) in a French Canadian family with familial combined hyperlipemia. Arterioscler. Thromb. Vasc. Biol. 26 7 (2006) 1619-1625
29. Maslowska M., Legakis H., Assadi F., et al. Targeting the signaling pathway of acylation stimulating protein. J. Lipid Res. 47 3 (2006) 643-652
30. Maslowska M., Vu H., Phelis S., et al. Plasma acylation stimulating protein, adipsin and lipids in non-obese and obese populations. Eur. J. Clin. Invest. 29 8 (1999) 679-686
31. Maslowska M., Wang H.W., and Cianflone K. Novel roles for acylation stimulating protein/C3adesArg: a review of recent in vitro and in vivo evidence. Vitam. Horm. 70 (2005) 309-332
32. Murray I., Köhl J., and Cianflone K. Acylation-stimulating protein (ASP): structure-function determinants of cell surface binding and triacylglycerol synthetic activity. Biochem. J. 342 Pt 1 (1999) 41-48
33. Murray I., Parker R.A., Kirchgessner T.G., et al. Functional bioactive recombinant acylation stimulating protein is distinct from C3a anaphylatoxin. J. Lipid Res. 38 12 (1997) 2492-2501
34. Okinaga S., Slattery D., Humbles A., et al. C5L2, a nonsignaling C5A binding protein. Biochemistry 42 31 (2003) 9406-9415
35. Otto M., Hawlisch H., Monk P.N., et al. C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism. J. Biol. Chem. 279 1 (2004) 142-151
36. Paglialunga S., Schrauwen P., Roy C., et al. Reduced adipose tissue triglyceride synthesis and increased muscle fatty acid oxidation in C5L2 knockout mice. J. Endocrinol. 194 2 (2007) 293-304
37. Pattrick M., Luckett J., Yue L., et al. Dual role of complement in adipose tissue. Mol. Immunol. 46 5 (2009) 755-760
38. Qiu Y., Loh H.H., and Law P.Y. Phosphorylation of the delta-opioid receptor regulates its beta-arrestins selectivity and subsequent receptor internalization and adenylyl cyclase desensitization. J. Biol. Chem. 282 31 (2007) 22315-22323
39. Rasouli N., and Kern P.A. Adipocytokines and the metabolic complications of obesity. J. Clin. Endocrinol. Metab. 93 11 Suppl. 1 (2008) S64-S73
40. Rittirsch D., Flierl M.A., Nadeau B.A., et al. Functional roles for C5a receptors in sepsis. Nat. Med. 14 5 (2008) 551-557
41. Scola A.M., Higginbottom A., Partridge L.J., et al. The role of the N-terminal domain of the complement fragment receptor C5L2 in ligand binding. J. Biol. Chem. 282 6 (2007) 3664-3671
42. Scola A.M., Johswich K.O., Morgan B.P., et al. The human complement fragment receptor, C5L2, is a recycling decoy receptor. Mol. Immunol. 46 6 (2009) 1149-1162
43. Ward P.A. Functions of C5a receptors. J. Mol. Med. 87 4 (2009) 375-378
44. Wen Y., Wang H., MacLaren R., et al. Sex steroid hormones induce acylation stimulating protein resistance in 3T3-L1 adipocytes. J. Cell. Biochem. 105 2 (2008) 404-413
45. Wen Y., Wang H., MacLaren R., et al. Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytes. J. Cell. Biochem. 104 May (2) (2008) 391-401
46. Xiong S., Wang Y.F., Ren X.R., et al. Solubility of disulfide-bonded proteins in the cytoplasm of Escherichia coli and its "oxidizing" mutant. World J. Gastroenterol. 11 7 (2005) 1077-1082